K. Zeldin Robert's most recent trade in MeiraGTx Holdings plc was a trade of 90,000 Restricted Share Units done . Disclosure was reported to the exchange on April 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2025 | 90,000 | 90,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 15,000 | 142,423 (0%) | 0% | - | Ordinary Shares | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 21 Feb 2025 | 5,903 | 136,520 (0%) | 0% | 7.3 | 43,092 | Ordinary Shares |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 37,500 | 142,572 (0%) | 0% | - | Ordinary Shares | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 37,500 | 0 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 14 Jan 2025 | 15,149 | 127,423 (0%) | 0% | 5.8 | 87,410 | Ordinary Shares |
| MeiraGTx Holdings plc | Robert Zeldin K. | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 70,000 | 70,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | K. Zeldin Robert | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 37,500 | 37,500 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | K. Robert Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 37,500 | 104,480 (0%) | 0% | - | Ordinary Shares | |
| MeiraGTx Holdings plc | K. Robert Zeldin | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.36 per share. | 14 Jan 2024 | 14,756 | 89,724 (0%) | 0% | 6.4 | 93,848 | Ordinary Shares |
| MeiraGTx Holdings plc | Robert Zeldin K. | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.30 per share. | 07 Jan 2024 | 13,773 | 71,714 (0%) | 0% | 6.3 | 86,770 | Ordinary Shares |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 30,000 | 30,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 75,000 | 80,000 (0%) | 0% | - | Ordinary Shares | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 75,000 | 75,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.99 per share. | 14 Jan 2023 | 29,513 | 50,487 (0%) | 0% | 7.0 | 206,296 | Ordinary Shares |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 7.90 per share. | 03 Jun 2022 | 4,994 | 4,994 (0%) | 0% | 7.9 | 39,453 | Ordinary Shares |
| MeiraGTx Holdings plc | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 7.83 per share. | 03 Jun 2022 | 6 | 5,000 (0%) | 0% | 7.8 | 47 | Ordinary Shares |
| MeiraGTx Holdings plc | Robert K. Zeldin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 70,000 | 70,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Robert K. Zeldin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| MeiraGTx Holdings plc | Robert K. Zeldin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 150,000 | 150,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Robert K. Zeldin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |